Vertex management update

Vertex Pharmaceuticals Inc. (NASDAQ:VRTX), Boston, Mass. Business: Infectious, Autoimmune, Pulmonary Transitioned: David Altshuler to EVP of global research and CSO from a director, effective early 20...